Lung cancer remains the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for 80-85 percent cases of lung cancer and when diagnosed early, has a five-year survival rate of 50-80 percent. ...
Jun 22, 2021
0
1
A nationwide study in Sweden estimates the elevated risk of advanced or fatal prostate cancer among relatives of men with the disease, providing new data that could help refine guidelines for the age at which screening should ...
Jun 01, 2021
0
6
Ovarian cancer is a tough diagnosis to cope with, and now a new study finds these patients face a much higher risk of depression and other mental health issues.
Apr 12, 2021
0
12
Men who have had treatment for early stage testicular cancer could benefit from fewer monitoring scans, freeing them from some of the harmful radiation that comes from computerized tomography (CT) imaging, according to results ...
Feb 15, 2021
0
2
A new advanced computing technique using routine medical scans to enable doctors to take fewer, more accurate tumour biopsies, has been developed by cancer researchers at the University of Cambridge. This is an important ...
Jan 06, 2021
0
18
Patients with locally advanced cervical cancer benefit significantly from an innovative radiotherapy technique co-developed by MedUni Vienna under the direction of Richard Pötter and Christian Kirisits. The technique provides ...
Nov 27, 2020
0
3
Israel began clinical trials of a novel coronavirus vaccine on Sunday, authorities said, as the government loosens a second lockdown imposed to stem soaring infections.
Nov 01, 2020
0
11
People with pale colored melanomas are more likely to have a gene mutation associated with albinism, University of Queensland research has found.
Sep 23, 2020
0
4
Yale Cancer Center (YCC) scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer. These results ...
Jun 29, 2020
0
2
In 2017 and 2019, the German Institute for Quality and Efficiency in Health Care (IQWiG) had already examined the advantages and disadvantages of ribociclib in combination with an aromatase inhibitor or fulvestrant in comparison ...
Jun 05, 2020
0
3
